Postpericardiotomy syndrome: Difference between revisions

Jump to navigation Jump to search
Line 99: Line 99:
* [[Cardiac biomarker]] testing is usually not helpful as it has not been shown to differ between those patients with and those without postpericardiotomy syndrome.
* [[Cardiac biomarker]] testing is usually not helpful as it has not been shown to differ between those patients with and those without postpericardiotomy syndrome.
* Send pericardial fluid for CBC and differential, culture and sensitivity, gram stain, protein and triglyceride level
* Send pericardial fluid for CBC and differential, culture and sensitivity, gram stain, protein and triglyceride level
==Chest X Ray==
*Often a [[pericardial effusion]] is present with blunting of the costophrenic angles.
*[[Cardiomegaly]] may be present if there is a sufficient pericardial effusion


==Treatment==
==Treatment==

Revision as of 02:10, 12 September 2012

Postpericardiotomy syndrome
Fibrinous pericarditis: Gross, natural color, excellent external view of typical fibrinous pericarditis (After mitral valve replacement).
Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

Pericarditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

HIV
Post MI
Dressler's syndrome
Post-pericardiotomy
Radiation
Tuberculosis
Uremia
Malignancy

Differentiating Pericarditis from other Diseases

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Pericardial Effusion
Cardiac Tamponade
Constrictive Pericarditis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Pericardiocentesis
Pericardial Window
Pericardial Stripping

Treatment Related Videos

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Postpericardiotomy syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Postpericardiotomy syndrome

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Postpericardiotomy syndrome

CDC on Postpericardiotomy syndrome

Postpericardiotomy syndrome in the news

Blogs on Postpericardiotomy syndrome

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Postpericardiotomy syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and Related Keywords: Postcommissurotomy syndrome; PCS; PPS

Overview

The postpericardiotomy syndrome is inflammation of the pericardium (the sac surrounding the heart) following cardiac surgery. Symptoms can occur from days to weeks after the operation. The syndrome is thought to have an autoimmune basis.

Pathophysiology

It has been postulated that the syndrome is an autoimmune response to pericardial and/or pleural bleeding or surgical trauma. Various viral agents, including coxsackie B, adenovirus, and cytomegalovirus, are identified in approximately two thirds of patients with postpericardiotomy syndrome, suggesting that postpericardiotomy syndrome is an autoimmune response that may be associated with a coincident viral infection.[1][2]

Causes

Conditions that Postpericardiotomy Syndrome should be Distinguished From

Postpericardiotomy syndrome should be distinguished from Dressler's syndrome which is an autoimmune process that occurs 2-10 weeks following ST elevation MI [13]. It should also be differentiated from the much more common post myocardial infarction pericarditis that occurs between days 2 and 4 after myocardial infarction. Postpericardiotomy syndrome should also be differentiated from pulmonary embolism, another cause of pleuritic chest pain in people who have been hospitalized and/or undergone surgical procedures within the preceding weeks.

Risk Factors

Postpericardiotomy syndrome occurs more frequently in patients who have undergone heart surgery that involves opening the pericardium.

Epidemiology and Demographics

It is estimated that anywhere from 2% to 30% of patients who undergo heart surgery who have had their pericardium opened will develop postpericardiotomy syndrome.

Age

The risk of postpericardiotomy syndrome increases with age.

  • Infants: Uncommon
  • Children: Not uncommon
  • Adults: Common, occurs in 30% of patients following surgery in which the pericardium is opened

Natural History, Complications, Prognosis

Natural History

The onset of symptoms is 1 to 6 weeks after cardiac surgery. In general the disease is self-limited and the symptoms and signs are mild and resolve in 2 to 3 weeks.

Complications

  • Pericardial effusion may result from the accumulation of fluids as a result of inflammation in the pericardial sac.
  • Cardiac tamponade can occur if the accumulation of fluids in the pericardium is large enough and rapid enough. This occurs in <1% of patients.
  • Constrictive pericarditis can occur if there is a chronic inflammatory response

Prognosis

In general the prognosis is good.

Diagnosis

Symptoms

Symptoms usually become manifest several (1 to 6) weeks after heart surgery and may include:

Physical Examination

Vital signs

Tachycardia may be present Hypoxemia may be present

Cardiac

Pericardial friction rub is often present, an enlarged heart may be present

Lungs

Signs of a pleural effusion may be present

Abdominal Exam

Hepatomegaly may be present

Extremities

Pedal edema may be present if pericardial constriction or a pericardial effusion is present

Laboratory Studies

  • CBC will be elevated with a leukocytosis and a leftward shift
  • ESR will be elevated
  • CRP will be elevated
  • Given the presence of fever and the post-operative status of the patient, blood cultures should be obtained to rule out endocarditis.
  • Antiheart antibodies are elevated
  • Cardiac biomarker testing is usually not helpful as it has not been shown to differ between those patients with and those without postpericardiotomy syndrome.
  • Send pericardial fluid for CBC and differential, culture and sensitivity, gram stain, protein and triglyceride level

Chest X Ray

Treatment

Postpericardiotomy syndrome is typically treated similar to Dressler's syndrome with high dose (up to 650 mg PO q 4 to 6 hours) enteric-coated aspirin. Acetominophen can be added for pain management as this does not affect the coagulation system. Anticoagulants should be discontinued if the patient develops a pericardial effusion.

NSAIDs such as ibuprofen should be avoided in the peri-infarct period as they:

  1. Increase the risk of reinfarction
  2. Adversely impact left ventricular remodeling.
  3. Block the effectiveness of aspirin
  4. May cause increased bleeding

ACC/AHA Treatment Guidelines (DO NOT EDIT)[14]

Class I

1. Aspirin is recommended for treatment of pericarditis after STEMI. Doses as high as 650 mg orally (entericcoated) every 4 to 6 hours may be needed. (Level of Evidence: B)

2. Anticoagulation should be immediately discontinued if pericardial effusion develops or increases. (Level of Evidence: C)

Class IIa

1. For episodes of pericarditis after STEMI that are not adequately controlled with aspirin, it is reasonable to administer 1 or more of the following:

a. Colchicine 0.6 mg orally every 12 hours (Level of Evidence: B)
b. Acetaminophen 500 mg orally every 6 hours. (Level of Evidence: C)

Class IIb

1. Corticosteroids might be considered only as a last resort in patients with pericarditis refractory to aspirin or NSAIDs. Although corticosteroids are effective for pain relief, their use is associated with an increased risk of scar thinning and myocardial rupture. (Level of Evidence: C)

2. Nonsteroidal anti-inflammatory drugs may be considered for pain relief; however, they should not be used for extended periods because of their effect on platelet function, an increased risk of myocardial scar thinning, and infarct expansion. (Level of Evidence: B)

Class III

1. Ibuprofen should not be used for pain relief because it blocks the antiplatelet effect of aspirin and it can cause myocardial scar thinning and infarct expansion. (Level of Evidence: B)

Sources

  • The 2004 ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction [14]
  • The 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction [15]

References

  1. Andreev DA, Giliarov MIu, Syrkin AL, Udovichenko AE, Gerok DV (2008). "[Postcardiotomy syndrome outside a cardiosurgical clinic]". Klin Med (Mosk). 86 (10): 67–71. PMID 19069464.
  2. Hazelrigg SR, Mack MJ, Landreneau RJ, Acuff TE, Seifert PE, Auer JE (1993). "Thoracoscopic pericardiectomy for effusive pericardial disease". Ann Thorac Surg. 56 (3): 792–5. PMID 8379795.
  3. Gungor B, Ucer E, Erdinler IC. Uncommon presentation of postcardiac injury syndrome: Acute pericarditis after percutaneous coronary intervention. Int J Cardiol. Aug 14 2007
  4. Peters RW, Scheinman MM, Raskin S, Thomas AN. Unusual complications of epicardial pacemakers. Recurrent pericarditis, cardiac tamponade and pericardial constriction. Am J Cardiol. May 1980;45(5):1088-94.
  5. Vinit J, Sagnol P, Buttard P, Laurent G, Wolf JE, Dellinger A. Recurrent delayed pericarditis after pacemaker implantation: a post-pericardiotomy-like syndrome?. Rev Med Interne. Feb 2007;28(2):137-40.
  6. Zeltser I, Rhodes LA, Tanel RE, Vetter VL, Gaynor JW, Spray TL. Postpericardiotomy syndrome after permanent pacemaker implantation in children and young adults. Ann Thorac Surg. Nov 2004;78(5):1684-7.
  7. Sasaki A, Kobayashi H, Okubo T, Namatame Y, Yamashina A. Repeated postpericardiotomy syndrome following a temporary transvenous pacemaker insertion, a permanent transvenous pacemaker insertion and surgical pericardiotomy. Jpn Circ J. Apr 2001;65(4):343-4.
  8. Goutal H, Baur F, Bonnevie L, Monnier G, Le Blainvaux M, Brion R. Postpericardiotomy syndrome; a rare complication of transcavitary cardiac pacing: apropos of a case. Arch Mal Coeur Vaiss. Dec 1995;88(12):1901-3.
  9. Hargreaves M, Bashir Y. Postcardiotomy syndrome following transvenous pacemaker insertion. Eur Heart J. Jul 1994;15(7):1005-7.
  10. Goodkind MJ, Bloomer WE, Goodyer AV. Recurrent pericardial effusion after nonpenetrating chest trauma: report of two cases treated with adrenocortical steroids. N Engl J Med. Nov 3 1960;263:874-81.
  11. Tabatznik B, Isaacs JP. Postpericardiotomy syndrome following traumatic hemopericardium. Am J Cardiol. Jan 1961;7:83-96.
  12. Peter RH, Whalen RE, Orgain ES, McIntosh HD. Postpericardiotomy syndrome as a complication of percutaneous left ventricular puncture. Am J Cardiol. Jan 1966;17(1):86-90.
  13. Krainin F, Flessas A, Spodick D (1984). "Infarction-associated pericarditis. Rarity of diagnostic electrocardiogram". N Engl J Med. 311 (19): 1211–4. PMID 6493274.
  14. 14.0 14.1 Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK (2004). "ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction)". Circulation. 110 (9): e82–292. PMID 15339869. Unknown parameter |month= ignored (help)
  15. Antman EM, Hand M, Armstrong PW; et al. (2008). "2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee". Circulation. 117 (2): 296–329. doi:10.1161/CIRCULATIONAHA.107.188209. PMID 18071078. Unknown parameter |month= ignored (help)

Template:SIB

Template:WikiDoc Sources